Liquidia LQDA
NASDAQ LQDA
$28.64 +0.65 (+2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liquidia (LQDA) Non Operating Interest Expenses (2020 - 2026)

Updated

Liquidia's Non Operating Interest Expenses came in at $6.3 million for Q2 2026, up 11.3% from $5.66 million a year earlier but down 3.0% from the prior quarter.

Analysis

Liquidia (LQDA) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Liquidia reported Non Operating Interest Expenses of $26.63 million, up 44.0% year-over-year; for FY2025, it was $24.17 million, up 65.0% from FY2024.

  • Non Operating Interest Expenses has increased in each of the last four years, with a five-year compound annual growth rate of 95.0% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $14.65 million in FY2024 (+133.6%), $6.27 million in FY2023 (+168.3%), $2.34 million in FY2022 (+206.8%) and $762,000 in FY2021 (-11.2%).
  • The five-year range for quarterly Non Operating Interest Expenses is $204,000 (Q4 2021) to $6.95 million (Q3 2025).
  • Year-over-year, Non Operating Interest Expenses has increased for 20 consecutive quarters, with growth averaging 68.6% over the last eight quarters.
  • Across the past five years, year-over-year growth in Non Operating Interest Expenses ran from 1.3% in Q4 2021 to 242.2% in Q4 2022.
  • Business Quant data shows LQDA's Non Operating Interest Expenses at $6.49 million (Q1 2026), $6.9 million (Q4 2025) and $6.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Liquidia 2.70 Bn 1.84 Bn 160.13 Mn 6.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.30 Mn
Mar 31, 2026 6.49 Mn
Dec 31, 2025 6.90 Mn
Sep 30, 2025 6.95 Mn
Jun 30, 2025 5.66 Mn
Mar 31, 2025 4.67 Mn
Dec 31, 2024 4.51 Mn
Sep 30, 2024 3.66 Mn
Jun 30, 2024 3.33 Mn
Mar 31, 2024 3.16 Mn
Dec 31, 2023 1.96 Mn
Sep 30, 2023 1.76 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.12 Mn
Dec 31, 2022 698,000.00
Sep 30, 2022 620,000.00
Jun 30, 2022 542,000.00
Mar 31, 2022 478,000.00
Dec 31, 2021 204,000.00
Sep 30, 2021 205,000.00
API Access

Liquidia Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LQDA&period=max&api_key=YOUR_API_KEY